Michael Garnreiter Sells 1,000 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $380.99, for a total transaction of $380,990.00. Following the completion of the transaction, the director now directly owns 27,259 shares in the company, valued at approximately $10,385,406.41. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Axon Enterprise Trading Up 0.1 %

NASDAQ AXON opened at $383.01 on Thursday. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $387.61. The firm’s fifty day simple moving average is $342.26 and its 200-day simple moving average is $315.72. The company has a market capitalization of $28.94 billion, a PE ratio of 111.99, a price-to-earnings-growth ratio of 10.34 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s quarterly revenue was up 34.5% on a year-over-year basis. During the same period last year, the business earned $0.80 EPS. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Institutional Trading of Axon Enterprise

A number of institutional investors have recently added to or reduced their stakes in AXON. Norges Bank bought a new position in shares of Axon Enterprise during the 4th quarter valued at $195,406,000. Motley Fool Asset Management LLC raised its holdings in Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. acquired a new stake in shares of Axon Enterprise in the first quarter worth about $81,630,000. Vanguard Group Inc. boosted its stake in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after acquiring an additional 212,401 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Axon Enterprise by 110.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company’s stock valued at $71,302,000 after acquiring an additional 144,568 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AXON has been the subject of a number of research reports. Northland Securities raised their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Barclays raised their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Robert W. Baird upped their target price on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Finally, Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $365.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.